Literature DB >> 12370191

Cell killing by HIV-1 protease.

Raquel Blanco1, Luis Carrasco, Iván Ventoso.   

Abstract

The human immunodeficiency virus protease (HIV-1 PR) was expressed both in the yeast Saccharomyces cerevisiae and in mammalian cells. Inducible expression of HIV-1 PR arrested yeast growth, which was followed by cell lysis. The lytic phenotype included loss of plasma membrane integrity and cell wall breakage leading to the release of cell content to the medium. Given that neither poliovirus 2A protease nor 2BC protein, both being highly toxic for S. cerevisiae, were able to produce similar effects, it seems that this lytic phenotype is specific of HIV-1 PR. Drastic alterations in membrane permeability preceded the lysis in yeast expressing HIV-1 PR. Cell killing and lysis provoked by HIV-1 PR were also observed in mammalian cells. Thus, COS7 cells expressing the protease showed increased plasma membrane permeability and underwent lysis by necrosis with no signs of apoptosis. Strikingly, the morphological alterations induced by HIV-1 PR in yeast and mammalian cells were similar in many aspects. To our knowledge, this is the first report of a viral protein with such an activity. These findings contribute to the present knowledge on HIV-1-induced cytopathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370191     DOI: 10.1074/jbc.M205636200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Diversification and specialization of HIV protease function during in vitro evolution.

Authors:  Taryn L O'Loughlin; Dina N Greene; Ichiro Matsumura
Journal:  Mol Biol Evol       Date:  2006-01-19       Impact factor: 16.240

Review 2.  Aging and cell death in the other yeasts, Schizosaccharomyces pombe and Candida albicans.

Authors:  Su-Ju Lin; Nicanor Austriaco
Journal:  FEMS Yeast Res       Date:  2013-11-08       Impact factor: 2.796

Review 3.  On the cutting edge: protease-based methods for sensing and controlling cell biology.

Authors:  H Kay Chung; Michael Z Lin
Journal:  Nat Methods       Date:  2020-07-13       Impact factor: 28.547

4.  Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4+ T Cells following Latency Reversal.

Authors:  Jennifer M Zerbato; Gilda Tachedjian; Nicolas Sluis-Cremer
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

5.  RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.

Authors:  Mayra Solis; Peyman Nakhaei; Mohammad Jalalirad; Judith Lacoste; Renée Douville; Meztli Arguello; Tiejun Zhao; Michael Laughrea; Mark A Wainberg; John Hiscott
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

6.  Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.

Authors:  Kristen A Porter; Lauren N Kelley; Annette George; Jonathan A Harton; Karen M Duus
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

7.  Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.

Authors:  Dirk Jochmans; Maria Anders; Inge Keuleers; Liesbeth Smeulders; Hans-Georg Kräusslich; Günter Kraus; Barbara Müller
Journal:  Retrovirology       Date:  2010-10-15       Impact factor: 4.602

8.  Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.

Authors:  Zilin Nie; Gary D Bren; Stacey R Vlahakis; Alicia Algeciras Schimnich; Jason M Brenchley; Sergey A Trushin; Sarah Warren; David J Schnepple; Colin M Kovacs; Mona R Loutfy; Daniel C Douek; Andrew D Badley
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

9.  Overexpression, Purification and Functional Characterisation of Wild-Type HIV-1 Subtype C Protease and Two Variants Using a Thioredoxin and His-Tag Protein Fusion System.

Authors:  Jake Zondagh; Alison Williams; Ikechukwu Achilonu; Heini W Dirr; Yasien Sayed
Journal:  Protein J       Date:  2018-08       Impact factor: 2.371

10.  Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity.

Authors:  Samuel J Resnick; Sho Iketani; Seo Jung Hong; Arie Zask; Hengrui Liu; Sungsoo Kim; Schuyler Melore; Fang-Yu Lin; Manoj S Nair; Yaoxing Huang; Sumin Lee; Nicholas E S Tay; Tomislav Rovis; Hee Won Yang; Li Xing; Brent R Stockwell; David D Ho; Alejandro Chavez
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.